Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fluoroquinolones-Associated Disability: It Is Not All in Your Head
Maya Z. Freeman, Deanna N. Cannizzaro, Lydia F. Naughton, et al.
NeuroSci (2021) Vol. 2, Iss. 3, pp. 235-253
Open Access | Times Cited: 20

Showing 20 citing articles:

Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?
Aura Rusu, Alexandra‐Cristina Munteanu, Eliza Mihaela Arbănași, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 804-804
Open Access | Times Cited: 68
Long-term toxicity of fluoroquinolones: a comprehensive review
Narmin Hama amin Hussen, Shnyar Hamid Qadir, Heshu Sulaiman Rahman, et al.
Drug and Chemical Toxicology (2023) Vol. 47, Iss. 5, pp. 795-806
Closed Access | Times Cited: 14
Fluoroquinolones for the Prophylaxis of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis: Are They Losing Ground?
Simona Juncu, Horia Minea, A Lungu, et al.
Life (2025) Vol. 15, Iss. 4, pp. 586-586
Open Access
The safety profiles of fluoroquinolones
A.‐P. Jonville‐Béra, Bérenger Largeau, Ferderico di Meglio, et al.
Infectious Diseases Now (2025) Vol. 55, Iss. 4, pp. 105064-105064
Closed Access
A Literature Review of Movement Disorder Associated with Medications and Systemic Diseases
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
(2024)
Open Access | Times Cited: 3
Fluoroquinolone-Associated Movement Disorder: A Literature Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Medicines (2023) Vol. 10, Iss. 6, pp. 33-33
Open Access | Times Cited: 8
The Benefits and Challenges of Antibiotics–Non-Steroidal Anti-Inflammatory Drugs Non-Covalent Reaction
Ilma Nugrahani, Diar Herawati, Marlia Singgih Wibowo
Molecules (2023) Vol. 28, Iss. 9, pp. 3672-3672
Open Access | Times Cited: 7
Novel Inhibitors of SARS-CoV-2 RNA Identified through Virtual Screening
Gregory Mathez, Andrea Brancale, Valeria Cagno
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 15, pp. 6190-6196
Open Access | Times Cited: 1
A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study.
Stephen Muhi, Julia L. Marshall, D. O’Brien, et al.
Wellcome Open Research (2024) Vol. 9, pp. 488-488
Open Access | Times Cited: 1
Bright Morning Light Enhances Parasympathetic Activity at Night: A Pilot Study of Older People with Dementia, without a Pacemaker
Chuen-Ru Liu, Terry B. J. Kuo, Jwo‐Huei Jou, et al.
(2023)
Open Access | Times Cited: 3
Voltammetric Study of Lomefloxacin Transfer at the Interface between Two Immiscible Electrolyte Solutions: Ionic Partition, Photodegradation, and Sensing Applications
Muhammad Salman, Sang Hyuk Lee, Shinta Jeshycka, et al.
ChemElectroChem (2022) Vol. 9, Iss. 19
Closed Access | Times Cited: 3
Comparison of Rifaximin Alone and With Quinolones in the Primary Prevention of Spontaneous Bacterial Peritonitis in Patients With Decompensated Chronic Liver Disease
Tahir Zaman, Muhammad Bilal Ahmed Attari, Adeel Ahmad, et al.
Cureus (2024)
Open Access
A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study.
Stephen Muhi, Julia L. Marshall, D. O’Brien, et al.
Wellcome Open Research (2024) Vol. 9, pp. 488-488
Open Access
Bright Morning Lighting Enhancing Parasympathetic Activity at Night: A Pilot Study on Elderly Female Patients with Dementia without a Pacemaker
Chuen-Ru Liu, Terry B. J. Kuo, Jwo‐Huei Jou, et al.
Healthcare (2023) Vol. 11, Iss. 6, pp. 793-793
Open Access | Times Cited: 1
ANTIBIOTIC-RELATED ADVERSE EVENTS IN HOSPITALIZED CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS WITH FREQUENT EXACERBATION: A RETROSPECTIVE STUDY
AURELIA CRETU
FARMACIA (2023) Vol. 71, Iss. 4, pp. 848-855
Open Access | Times Cited: 1
Fluoroquinolone-Associated Disability and Other Fluoroquinolone-Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent Years
Charles L. Bennett, Oscar Champigneulle, Andrew C. Bennett, et al.
Cancer treatment and research (2022), pp. 1-39
Closed Access | Times Cited: 2
Levofloxacin-associated transient mixed sensorimotor lacunar syndrome
Francesco Michelassi, Joshua Bloom, Mark K. Su, et al.
BMJ Case Reports (2022) Vol. 15, Iss. 12, pp. e252052-e252052
Closed Access | Times Cited: 1
Moxifloxacin-induced mental status change
Sertaç Güler, Dilber Üçöz Kocaşaban
Acta Facultatis Medicae Naissensis (2023) Vol. 40, Iss. 1, pp. 123-127
Open Access
Antibiotic-induced neurological adverse drug reactions
Clémence Lacroix, Tessa Pietri, Vincent Montero, et al.
Therapies (2023) Vol. 79, Iss. 2, pp. 181-188
Closed Access
Is a Long-Lasting Fluoroquinolone Metabolite the Cause of Toxicity in Fluoroquinolone-Associated Disability? An Analysis of Smartwatch Data, Case Studies, Patient Statements and Pharmacokinetics
James A. R. Dalton
SSRN Electronic Journal (2021)
Closed Access
Page 1

Scroll to top